Venture capital market
Get more with myNEWS
A personalised news feed of stories that matter to you
Learn more
Bao Fan, founder of China Renaissance. Photo: SCMP/Nora Tam

Top tech deal maker warns China’s venture capital winter is far from over

  • Investors in private equity and venture capital funds, known as limited partners, are becoming a lot more selective before committing capital
  • Venture capital and private equity funds raised US$3 billion in the first four months of 2022, down more than 90 per cent compared to a year ago

Chinese start-ups will struggle to attract investment throughout 2022 and possibly beyond, one of the country’s most successful deal makers said, adding to a chorus of warnings about a reckoning for global tech firms after years of easy money.

Investors in private equity and venture capital funds, known as limited partners, are becoming a lot more selective before committing capital, Bao Fan, founder of China Renaissance Holdings, told Bloomberg News in Hong Kong. The industry may be witnessing the start of a longer-term shift in the geography and type of investor, as American and risk-averse backers begin to cool on China, he said in an interview.

“It’s very difficult for new funds – especially the first-timers – to raise capital under current circumstances,” the 52-year old financier said. “No one knows when this will end.”

Singapore’s Golden Gate targets Vietnam’s emerging tech sector

The former Morgan Stanley and Credit Suisse banker should know. He has had his finger on the pulse of China’s tech and VC ecosystem over the past two decades, having been an early investor in big names like Didi Global and Meituan as well as a bookrunner on’s US$2 billion US initial public offering in 2014. Last year, his company was a top underwriter for Kuaishou Technology’s Hong Kong listing, the biggest internet IPO since Uber Technologies’ debut in 2019.

His near-term outlook adds to a frosty mood around investments into China, which was recently dubbed “uninvestable” by JPMorgan Chase & Co analysts following a withering year of government regulations, Covid-19 disruptions and geopolitical tensions battering the country’s economy. JPMorgan analysts later revised that assessment.

“At the end of the day, investment is to make money,” Bao said. “If the market is not good, it will definitely affect everybody’s enthusiasm for investment.” The Nasdaq Golden Dragon China Index – a benchmark tracking Chinese stocks listed in the US – slid roughly 20 per cent this year. Meanwhile, Hong Kong’s closely-watched Hang Seng Index has fallen 9 per cent.

Fundraising for new ventures in the country has fallen off a cliff, mirroring the performance of its best-known tech stocks like Alibaba Group Holding (owner of the Post) and Tencent Holdings, which have been in the crosshairs of a wide-ranging Beijing crackdown on internet firms. Venture capital and private equity funds raised US$3 billion in the first four months of 2022, marking a decline of more than 90 per cent compared to a year ago, according to estimates from industry data provider Preqin.

Markets all over the world are going through a painful rethink about the lofty valuations they have put on tech stocks, and China is leading the way with a decline in VC deals this year that is nearly four times the pace of the global slide, Preqin’s figures showed.

Nomura leads US$6 million investment in Hong Kong start-up Allinfra

As a frontline fundraiser, Bao has witnessed a pullback from many US and European investors. But at the same time, he sees emerging markets increasingly stepping in to fill the void for China-focused private equity investors.

China Renaissance managed 48.9 billion yuan (US$7.3 billion) across its 10 private equity funds as of December 2021, according to its most recent filing. Some of his portfolio companies, such as Shenzhen-based MGI Tech, which provides advanced gene-sequencing solutions to healthcare companies, could use the Middle East as its launch pad for going global, Bao said.

He has also backed companies that provide smart industrial technology used in supply chains, contracts and transactions – advanced manufacturing is another area of interest for many in Southeast Asia, for instance.

Bao’s ability to connect rising Chinese companies with investors in emerging markets may hold the key for his team to fend off competition from the likes of KKR & Co and Tiger Global Management, which in recent years are also increasingly turning to deep-pocketed Middle East investors for funding.

Bao’s sales pitch appears to be resonating with regional funders. From a total of US$800 million raised as of early 2022 for his Huaxing Growth Capital Fund IV, 60 per cent of that came from Asian investors including those from the Middle East, while American investors chipped in only 2 per cent, according to China Renaissance.

At home, Bao sees good opportunity in sectors that align with Beijing’s long-term tech ambition, such as manufacturing automation and so-called deep tech, businesses that will help resolve the supply chain bottlenecks that gripped the world for much of the past two years. It is a tricky market to navigate, with Beijing reining in internet companies and Washington threatening to expel more than 200 US-listed Chinese firms.

But if you believe China’s economy will eventually regain momentum and strength, now is a good time to invest in its companies, according to Bao.

“The uglier the market, the more attractive the opportunities it yields for investors, unless you truly believe China is uninvestable,” he said.